About Xiaowei Jin
Form D filings for NeuroLambda Therapeutics in 2024 list Xiaowei Jin as director.
Xiaowei Jin first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Xiaowei Jin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Xiaowei Jin works with at each company, as listed on that company's latest Form D.
NeuroLambda Therapeutics, Inc. · Form D, Jul 17, 2024
BK
Byungchan Kim
Director
SM
Sayan Mondal
President and director